Global HIV Therapeutics Market Analysis to 2019 – JSB Market Research

Global HIV Therapeutics Market Analysis to
2019 - Limited Pipeline Efficacy Improvement,
Patent Expirations and Stringent Healthcare
Spending to Suppress Market Growth
Released On 9 th June 2015
Global HIV Therapeutics Market Analysis to 2019 - Limited Pipeline Efficacy
Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress
Market Growth provides insights into the HIV (Human Immunodeficiency Virus)
therapeutics market including market forecasts up to 2019. It provides an in-depth
analysis of the major marketed products, as well as insights into the HIV therapeutics
R&D pipeline.
The HIV therapeutic market report provides in-depth analysis of the unmet needs,
drivers and barriers that affect the global HIV therapeutics market. The report analyzes
the market for HIV therapeutics in eight major markets of the US, the top five countries
in Europe (the UK, Germany, France, Italy and Spain), Japan and Canada. The report
discusses the global pipeline for all the HIV molecules across various stages of
development.
The report is built using data and information sourced from proprietary databases,
primary and secondary research and in-house analysis by a team of industry experts.
The authors found that the HIV therapeutics market in the top seven markets was
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

valued at $14.3 billion in 2012 and is projected to witness HIV therapeutics market
growth of 1.9% during the 2012–2019 forecast period to reach $16.3 billion.
Scope
The report analyzes treatment usage patterns, drug types available and pipeline and
market forecasts across indications for HIV. The Global HIV Therapeutics Market
Analysis report covers and includes -
A brief introduction to HIV, including the symptoms, pathogenesis, risk factors and
diagnosis
In-depth analysis of major glucose-lowering drugs for HIV, including analyses of their
safety, efficacy, treatment patterns, strengths/weaknesses and
overall commercial prospects. Includes a heat map comparing major drugs in terms of
safety, efficacy and dosing parameters.
Comprehensive review of the pipeline for HIV therapies, including individual analysis
of a number of late-stage pipeline drugs that are likely to enter the market in the
forecast period. The pipeline is analyzed on the basis of phase distribution, molecule
types and molecular targets.
Additional in-depth analysis of pipeline drug clinical trials by phase, molecule type,
trial size, trial duration and program failure rate analyses for each molecule type and
mechanism of action
Multi-scenario forecast data for the market up to 2019, taking into account how it will
be affected by the introduction of new drugs, the expiry of key patents on current
drugs, and changes in disease epidemiology across key developed markets including
the US, Japan, Germany, the UK, France, Italy, Spain and Canada
Discussion of the drivers and barriers for market growth
Reasons to buy
The report will enhance your decision-making capability. It will allow you to -
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the potential
region and HIV/AIDS therapeutics market segments poised for strong growth.
Create a more tailored country strategy through the understanding of key drivers and
barriers of the global HIV/AIDS therapeutics market.
Develop key strategic initiatives by understanding the key focus areas and top selling
products of leading companies.
Accelerate and strengthen your market position by identifying key companies for
mergers, acquisitions and strategic partnerships.
Browse complete Report on:
http://www.jsbmarketresearch.com/healthcare-medical/r-hiv-therapeutics-
in-major-developed-markets-to-2019-limited-pipeline-efficacy-improvement-
151137
Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Disease Introduction
2.2 Route of HIV Transmission
2.3 Etiology
2.4 Classification of HIV-1 Subtypes
2.5 Pathophysiology
2.5.1 HIV-1 Replication Cycle
2.5.2 Mechanism of CD4 T-Cell Death
2.5.3 Latent Infection and Viral Persistence
se Inhibitor
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

2.6 Symptoms
2.7 Diagnosis
2.7.1 HIV Antibody Assay
2.7.2 Rapid HIV Antibody Test
2.7.3 Western Blot
2.7.4 HIV p24 Antigen Test
2.7.5 Antigen-Antibody Immunoassay
2.7.6 Polymerase Chain Reaction Test
2.7.7 HIV Home-Testing Kit
2.8 Disease Staging
2.8.1 WHO Clinical Staging
2.8.2 Centers for Disease Control and Prevention Classification System
2.8.3 Immunological Classification
2.9 Co-morbidities and Complications
2.10 Epidemiology
2.11 Treatment Options
2.11.1 Nucleoside/Nucleotide Reverse Transcriptase Inhibitor
2.11.2 Non-Nucleoside Reverse Transcriptase Inhibitor
2.11.3 Entry Inhibitor
2.11.4 Integrase Inhibitor
2.11.5 HIV-1 Protease Inhibitor
2.11.6 Pharmacokinetic Enhancer
2.12 Treatment Algorithm
3 Marketed Products
3.1 Therapeutic Landscape
3.1.1 Multi-class Combinations
3.1.2 Nucleotide Reverse Transcriptase Inhibitors
3.1.3 Non-Nucleoside Reverse Transcriptase Inhibitor
3.1.4 HIV Protease Inhibitor
3.1.5 Integrase Inhibitor
3.1.6 Entry Inhibitor
3.2 Comparative Efficacy and Safety
3.2.1 Multi-class Combination
3.2.2 Nucleotide Reverse Transcriptase Inhibitor
3.2.3 Non-Nucleotide Reverse Transcriptase Inhibitor
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

3.2.4 HIV Protease Inhibitor
3.2.5 Integrase Inhibitor
3.2.6 Entry Inhibitor
3.3 Unmet Need
4 Pipeline for HIV
4.1 Overall Pipeline
4.2 Mechanism of Action in HIV Pipeline
4.3 Clinical Trials
4.3.1 Failure Rate of Developmental Pipeline
4.3.2 Clinical Trial Sizes
4.3.3 Clinical Trial Duration
4.3.4 Summary of Clinical Trial and Risk Analysis
4.4 Promising Candidates in Pipeline
4.4.1 572-Trii (dolutegravir + abacavir sulfate + lamivudine) – Shionogi-ViiV Healthcare
4.4.2 Atazanavir sulfate + cobicistat – Bristol-Myers Squibb, Gilead
4.4.3 Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide – Gilead
4.4.4 Apricitabine – Avexa
4.4.5 Remune (IR-103) – Immune Response BioPharma
4.4.6 Censavudine – Bristol-Myers Squibb
4.4.7 Elvucitabine – Achillion
4.4.8 Cenicriviroc – Tobira Therapeutics
4.5 Heat Map and Competitor Matrix for HIV Pipeline Products
5 Market Forecast to 2019
5.1 Geographical Markets
5.1.1 Global Market
5.1.2 North America
5.1.3 Top Five Countries in Europe
5.1.4 Japan
5.2 Drivers and Barriers
5.2.1 Drivers
5.2.2 Barriers
6 Deals and Strategic Consolidations
6.1 Major Co-development Deals
6.1.1 DFH Pharma Enters Agreement with Hetero Drugs
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

6.1.2 GlaxoSmithKline Enters Agreement with Concert Pharmaceuticals
6.1.3 GenVec Enters Agreement with SAIC-Frederick
6.2 Major Licensing Deals
6.2.1 Merck Enters Agreement with Chimerix
6.2.2 Bristol-Myers Squibb Enters Agreement with Gilead
6.2.3 Japan Tobacco Enters Agreement with Gilead
6.2.4 Gilead Enters Agreement with Tibotec
6.2.5 Benitec Enters Agreement with Calimmune
6.2.6 Bristol-Myers Squibb Enters Agreement with Oncolys BioPharma
7 Appendix
7.1 All Pipeline Products, by Phase
7.1.1 Discovery
7.1.2 Preclinical
7.1.3 Phase I
7.1.4 Phase II
7.1.5 Phase III and Pre-registration
7.2 Tabular Forecast Data
7.2.1 Global
7.2.2 US
7.2.3 Canada
7.2.4 UK
7.2.5 France
7.2.6 Germany
7.2.7 Italy
7.2.8 Spain
7.2.9 Japan
7.3 Sources
7.4 Market Definition
7.5 Abbreviations
7.6 Research Methodology
7.6.1 Coverage
7.6.2 Secondary Research
7.7 Therapeutic Landscape
7.8 Epidemiology-Based Forecasting
7.9 Market Size by Geography
7.10 Geographical Landscape
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

7.11 Pipeline Analysis
7.12 Competitive Landscape
7.12.1 Expert Panel Validation
7.13 Contact Us
7.14 Disclaimer
List Of Tables
Table 1: HIV Therapeutics Market, Subtypes of HIV-1 and Geographical Patterns, 2013
Table 2: HIV Therapeutics Market, World Health Organizations Clinical Staging of
HIV/AIDS for Adults and Adolescents with Confirmed HIV Infection, 2014
Table 3: HIV Therapeutics Market, US Centers for Disease Control and Preventions
Classification System for Adults and Adolescents with HIV, 1993–2014
Table 4: HIV Therapeutics Market, World Health Organizations Immunological
Classification for Adults and Children with Established HIV, 2014
Table 5: HIV Therapeutics Market, Global, Expected Patent Expirations in the HIV
Market, 2013–2019 Table 6: All Pipeline Products, by Phase, Discovery
Table 7: All Pipeline Products, by Phase, Preclinical
Table 8: All Pipeline Products, by Phase, Phase I
Table 9: All Pipeline Products, by Phase, Phase II
Table 10: All Pipeline Products, by Phase, Phase III and Pre-registration
Table 11: HIV Theraputic Market, Global, Market Forecast, 2012-2019
Table 12: HIV Therapeutic Market, US, Market Forecast, 2012-2019
Table 13: HIV Therapeutic Market, Canada, Market Forecast, 2012-2019
Table 14: HIV Therapeutic Market, UK, Market Forecast, 2012-2019
Table 15: HIV Therapeutic Market, France, Market Forecast, 2012-2019
Table 16: HIV Therapeutic Market, Germany, Market Forecast, 2012-2019
Table 17: HIV Therapeutic Market, Italy, Market Forecast, 2012-2019
Table 18: HIV Therapeutic Market, Spain, Market Forecast, 2012-2019
Table 19: HIV Therapeutic Market, Japan, Market Forecast, 2012-2019
List Of Figures
Figure 1: HIV Therapeutics Market, Treatment Algorithm for HIV-infected Adults and
Adolescents under World Health Organization Guidelines, 2013
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

Figure 2: HIV Therapeutics Market, Treatment Algorithm for Infants and Children with
HIV under World Health Organization Guidelines, 2013
Figure 3: HIV Therapeutics Market, Global, Annual Sales of Key Marketed Products
($bn), 2013
Figure 4: HIV Therapeutics Market, Global, Annual Sales of Atripla ($bn), 2006–2013
Figure 5: HIV Therapeutics Market, Global, Annual Sales of Complera ($m), 2011–2013
Figure 6: HIV Therapeutics Market, Global, Annual Sales of Truvada ($bn), 2004–2013
Figure 7: HIV Therapeutics Market, Global, Annual Sales of Epzicom ($m), 2004–2013
Figure 8: HIV Therapeutics Market, Global, Annual Sales of Viread ($m), 2001–2013
Figure 9: HIV Therapeutics Market, Global, Annual Sales of Combivir ($m), 2000–2013
Figure 10: HIV Therapeutics Market, Global, Annual Sales of Trizivir ($m), 2000–2013
Figure 11: HIV Therapeutics Market, Global, Annual Sales of Epivir ($m), 1996–2013
Figure 12: HIV Therapeutics Market, Global, Annual Sales of Sustiva ($m), 2001–2013
Figure 13: HIV Therapeutics Market, Global, Annual Sales of Intelence ($m), 2010–2013
Figure 14: HIV Therapeutics Market, Global, Annual Sales of Reyataz ($m), 2003–2013
Figure 15: HIV Therapeutics Market, Global, Annual Sales of Prezista ($m), 2006–2013
Figure 16: HIV Therapeutics Market, Global, Annual Sales of Kaletra ($bn), 2009–2012
Figure 17: HIV Therapeutics Market, Global, Annual Sales of Norvir ($m), 2010–2012
Figure 18: HIV Therapeutics Market, Global, Annual Sales of Isentress ($m), 2007–2013
Figure 19: HIV Therapeutics Market, Global, Annual Sales of Selzentry ($m), 2010–2013
Figure 20: HIV Therapeutics Market, Global, Heat Map of Marketed Products, 2013
Figure 21: HIV Therapeutics Market, Global, Overall Pipeline, 2014
Figure 22: HIV Therapeutics Market, Global, Breakdown of Biologics and Vaccine, 2014
Figure 23: HIV Therapeutics Market, Global, Mechanism of Action in the Pipeline, 2014
Figure 24: HIV Therapeutics Market, Global, Clinical Trial Failure Rate by Molecule
Type, 2006–2013
Figure 25: HIV Therapeutics Market, Global, Clinical Trial Failure Rate by Mechanism of
Action, 2006–2013
Figure 26: HIV Therapeutics Market, Global, Clinical Trial Failure Reasons, 2006–2013
Figure 27: HIV Therapeutics Market, Global, Mean Recruitment Size of Clinical Trial by
Molecule Type (Participants), 2006–2013
Figure 28: HIV Therapeutics Market, Global, Mean Recruitment Size of Clinical Trial by
Mechanism of Action (Participants), 2006–2013
Figure 29: HIV Therapeutics Market, Global, Mean Duration of Clinical Trial by Molecule
Type (Months), 2006–2013*
Figure 30: HIV Therapeutics Market, Global, Mean Duration of clinical Trial by
Mechanism of Action (Months), 2006–2013
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

Figure 31: HIV Therapeutics Market, Global, Failure Rate, Duration and Recruitment
Size by Mechanism of Action, 2006–2013
Figure 32: HIV Therapeutics Market, Global, Sales Forecast for 572-Trii ($bn), 2014–
2019
Figure 33: HIV Therapeutics Market, Global, Sales Forecast for Atazanavir Sulfate +
Cobicistat ($m), 2014–2019
Figure 34: HIV Therapeutics Market, Global, Sales Forecast for Elvitegravir + Cobicistat
+ Emtricitabine + Tenofovir Alafenamide ($m), 2015–2019
Figure 35: HIV Therapeutics Market, Global, Sales Forecast for Apricitabine ($m), 2016–
2019
Figure 36: HIV Therapeutics Market, Global, Sales Forecast for Censavudine ($m),
2016–2019
Figure 37: HIV Therapeutics Market, Global, Sales Forecast for Elvucitabine ($m),
2016–2019
Figure 38: HIV Therapeutics Market, Global, Sales Forecast for Cenicriviroc ($m), 2016–
2019
Figure 39: HIV Therapeutics Market, Global, Heat Map of Pipeline Products, 2013
Figure 40: HIV Therapeutics Market, Global, Competitor Matrix, 2013
Figure 41: HIV Therapeutics Market, Global, Treatment Patterns and Market Size,
2012–2019
Figure 42: HIV Therapeutics Market, North America, Treatment Patterns, 2012–2019
Figure 43: HIV Therapeutics Market, North America, Annual Cost of Therapy ($), 2012–
2019
Figure 44: HIV Therapeutics Market, North America, Market Size, 2012–2019
Figure 45: HIV Therapeutics Market, Top Five European Countries, Treatment Patterns
(‘000), 2012–2019
Figure 46: HIV Therapeutics Market, Top Five European Countries, Annual Cost of
Therapy ($), 2012–2019
Figure 47: HIV Therapeutics Market, Top Five European Countries, Market Size ($m),
2012–2019
Figure 48: HIV Therapeutics Market, Japan, Treatment Patterns and Annual Cost of
Therapy, 2012–2019
Figure 49: HIV Therapeutics Market, Japan, Market Size ($m), 2012–2019
Figure 50: HIV Therapeutics Market, Global, Co-development Deals, 2006–2014*
Figure 51: HIV Therapeutics Market, Global, Co-development Deals, 2006–2014
Figure 52: HIV Therapeutics Market, Global, Licensing Deals, 2006–2014*
Figure 53: HIV Therapeutics Market, Global, Licensing Deals, 2006–2014
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

Figure 54: HIV Therapeutics Market, Global, Licensing Deals by Mechanism of Action,
2006–2014
Figure 55: Authors Market Forecasting Model
Buy 2 Reports Get 1 Free
Click Here For Special Discount Offer On Infiniti Research Limited
http://www.jsbmarketresearch.com/publisher/infiniti-research-limited
For more inquiries, contact at +91 - 998 729 5242
/contact@jsbmarketresearch.com
Product Price :
License Type
Price
PDF $ 4995
Site Licence $ 9990
Enterprise Wide Licence $ 14985
Related reports:
Electrophoresis Market by Product (1D & 2D Gel Electrophoresis, Agarose &
Polyacrylamide Gel, Capillary Electrophoresis, Isoelectric Focusing,
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

Isotachophoresis, CZE, CGE, MEKC, Reagents, Informatics), Application & End
User - Global Forecast to 2020
Oxidative Stress Assay Market by Product (Consumables, Instruments,
Services), Test Type (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-
based), Technology (ELISA, Chromatography, Flow Cytometry), End Users -
Global Forecast to 2020
European Microscopy Market by Product (Optical (Fluorescence, Super-
Resolution), Confocal, Electron (Transmission), Scanning (AFM)), Application
(Semiconductor, Life Science, Nanotechnology), End User (Academic Institute,
Industries) - Forecast to 2020
Global Vitreoretinal Surgery Devices Market by Types (Photocoagulation
Surgery Devices, Vitrectomy Surgery Devices, Illumination Surgery Devices),
by End Users (Private Eye Clinics & Hospitals) & by Geography - Analysis &
Forecast to 2019
Asian Departmental Picture Archiving and Communication System (PACS)
Market by Type (Radiology PACS, Cardiology PACS & Others) by Component by
Deployment and by End User (Hospitals, Laboratories, Office Based
Physicians) - Analysis and Forecast to 2019
Asian Advanced Wound Care Market by Method (Dressing, Graft), By
Application (Surgical Wound, Ulcer), by End-User (In-Patient & Out-Patient), &
by Geography - Analysis & Forecast to 2019
Asia Revenue Cycle Management System (RCM) Market by Product (Integrated
RCM, Standalone RCM), by Deployment (On-Premise, Web-Based, Cloud-
Based), by Component (Software, Hardware, Services), by End-User, by
Geography - Analysis and Forecast to 2019
Global Dental Lasers Market by Product [Soft-Tissue Lasers, All-Tissue
(Hard/Soft) Lasers], by End User (Hospitals, Dental Clinics) - Analysis and
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/

Forecast to 2019
Europe Spine Surgery Devices Market by Product (Spinal Fusion & Fixation
Devices, Spine Biologics, Non-Fusion Implants, Spine Bone Stimulators), by
End-User (Orthopedic Clinics & Spine Centers, Hospitals), by Geography –
Analysis & Forecast to 2019
Healthcare and Medical Market Research
You can order this report by calling on +91 - 998 7295 242 or mail us your
contact details at contact@jsbmarketresearch.com
About JSB Market Research:-
JSB market research is amongst the best online market research companies providing
the most significant online database of various industry research reports and services.
This online portal contains high-quality market research reports with well-researched
content on a wide range of industries. We specialize in providing the best market
research reports for various industries.
To know more on “Global HIV Therapeutics Market Analysis to 2019 - Limited
Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare
Spending to Suppress Market Growth”
http://www.jsbmarketresearch.com/c-medical/r-hiv-therapeutics-in-majordeveloped-markets-to-2019-limited-pipeline-efficacy-improvement-151137
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/